Lifeboat Foundation

The coronavirus outbreak is bringing attention to the fast-growing vaccine industry.

The vaccine market has grown sixfold over the past two decades, worth more than $35 billion today, according to AB Bernstein. The firm said the industry has consolidated to four big players that account for about 85% of the market — British drugmaker GlaxoSmithKline, French pharmaceutical company Sanofi, and U.S.-based Merck and Pfizer.

“For every dollar invested in vaccination in the world’s 94 lowest-income countries, the net return is $44. Hard to argue against,” Wimal Kapadia, Bernstein’s analyst, said in a note. “This oligopoly has been built through significant market consolidation driven primarily by the complexities of the manufacturing and supply chain.”

The CEO of UVD Robots explains why robots can be effective in fighting the coronavirus and how his company is scaling up to meet demand.

Wuhan Coronavirus Pandemic — USA

California has the first case that cannot be traced back to a traveler from an area with an outbreak.

“It’s significant because it means that it’s also possible the infection is spreading untraced throughout the local community.”

Continue reading “CDC confirms first possible community transmission of coronavirus in US” »

Photoacoustic imaging, a technique for examining living materials through the use of laser light and ultrasonic sound waves, has many potential applications in medicine because of its ability to show everything from organs to blood vessels to tumors.

Caltech’s Lihong Wang, a pioneer in the field, has developed variants of photoacoustic imaging that can show organs moving in real time, develop three-dimensional (3D) images of internal body parts, and even differentiate cancerous cells from healthy cells.

Wang, Bren Professor of Medical Engineering and Electrical Engineering, has now further advanced photoacoustic imaging technology with what he calls Photoacoustic Topography Through an Ergodic Relay (PATER), which aims to simplify the equipment required for imaging of this type.

The “powerhouse of the cell” is apparently not necessary for animal life.

Medicine to treat obsessive compulsive disorder.

For now, it’s a simple network. But, it could be an important first step toward smarter and more adaptive prosthetics and brain-computer interfaces — and potentially lay the groundwork for a world where neural implants create real brain networks.

“On one side it sets the basis for a novel scenario that was never encountered during natural evolution, where biological and artificial neurons are linked together and communicate across global networks; laying the foundations for the Internet of Neuro-electronics,” Themis Prodromakis, a nanotechnology researcher and director at the University of Southampton’s Centre for Electronics Frontiers said in a press release.

“On the other hand, it brings new prospects to neuroprosthetic technologies, paving the way towards research into replacing dysfunctional parts of the brain with AI chips.”

Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.

The team is participating in a global clinical trial to assess pulsed field ablation (PFA) technology to treat patients with atrial fibrillation. Developed by.

Ogba Educational Clinic

A nightmarish scene was burnt into my memory nearly two decades ago: Changainjie, Beijing’s normally chaotic “fifth avenue,” desolate without a sign of life. Schools shut, subways empty, people terrified to leave their homes. Every night the state TV channels reported new cases and new deaths. All the while, we had to face a chilling truth: the coronavirus, SARS, was so novel that no one understood how it spread or how to effectively treat it. No vaccines were in sight. In the end, it killed nearly 1,000 people.

It’s impossible not to draw parallels between SARS and the new coronavirus outbreak, COVID-19, that’s been ravaging China and spreading globally. Yet the response to the two epidemics also starkly highlights how far biotech and global collaborations have evolved in the past two decades. Advances in genetic sequencing technologies, synthetic biology, and open science are reshaping how we deal with potential global pandemics. In a way, the two epidemics hold up a mirror to science itself, reflecting both technological progress and a shift in ethos towards collaboration.

Continue reading “How to Battle an Epidemic? Digitize Its DNA and Share It With the World” »